Results for
"[search-keyword]"
Sponsor content
46 result(s) found, displaying 1 to 10
-
Jan-2024Prescription medicine evaluationActive ingredient: abaloparatide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRAROSA prasterone 6.5 mg pessary blister pack.
-
Australian Public Assessment Report (AusPAR)Intrarosa (prasterone) has been approved for the treatment of vulvar and vaginal atrophy.
-
Aug-2023Prescription medicine evaluationActive ingredient: linzagolix choline.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GANIRELIX THERAMEX ganirelix (as acetate) 250 microgram/0.5 mL solution for injection prefilled syringe.
-
Prescription medicine decision summaryTGA decision: Intrarosa (prasterone) is approved to treat vulvar and vaginal atrophy in postmenopausal women.
-
-
Australian Public Assessment Report (AusPAR)AusPAR for Bijuva 1/100 (estradiol hemihydrate and progesterone) for use during HRT for estrogen deficiency symptoms.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIJUVA 1/100 estradiol (as hemihydrate) 1 mg progesterone 100 mg capsule blister pack.
-
Prescription medicine registrationActive ingredients: Ganirelix.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Next page Next ›
- Last page Last »